Dr. Lauren Carole Pinter-Brown, MD

Dr. Pinter-Brown practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Pinter-Brown's NPI, 1669492252, was assigned on July 19, 2006. Dr. Pinter-Brown graduated from David Geffen School of Medicine at UCLA in 1980. Dr. Pinter-Brown holds California license G46124.

Dr. Pinter-Brown's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Pinter-Brown's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Pinter-Brown is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pinter-Brown practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pinter-Brown's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pinter-Brown is board certified in hematology by the American Board of Internal Medicine. Dr. Pinter-Brown is licensed in California.

Dmand AI lists chronic anemia, chronic embolism thrombosis, chronic leukemia, fluid and electrolyte imbalances, lymphoma and purpura and thrombocytopenia among the conditions Dr. Pinter-Brown treats.

CMS data shows 661 Medicare services from Dr. Pinter-Brown across 2 procedure codes in 2024, all of them office visits, for 239 Medicare patients. Medicare paid $68,133 for them.

CMS counts 239 Medicare patients who saw Dr. Pinter-Brown in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pinter-Brown's median patient age at 68, with 50% women.

In 2024, Dr. Pinter-Brown wrote 544 Medicare Part D claims for 84 patients. 75% of them were for generic drugs. CMS names the drug for 423 of them, across 17 drugs with 11 or more claims each, at $1,339,866 in total drug cost. In 2023, CMS named 208 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Pinter-Brown for performance year 2024, reported through an alternative payment model (APM). Dr. Pinter-Brown accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pinter-Brown as offering telehealth.

Dmand AI links 2 papers to Dr. Pinter-Brown in 2017. Dr. Pinter-Brown's most frequent co-authors are Ranjana Advani, MD, Kenneth Robert Carson, MD and Carla Casulo, MD.

Dmand AI links Dr. Pinter-Brown to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Lymphoma, Large B-Cell, Diffuse, Sezary Syndrome and Leukemia-Lymphoma, Adult T-Cell. Jonsson Comprehensive Cancer Center sponsors the most, 2.

CMS Open Payments shows 151 general payments to Dr. Pinter-Brown from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Seagen Inc. paid the most, $17,588. It also lists 2 research payments totaling $1,233 in 2024.

Dmand AI lists 1 award for Dr. Pinter-Brown.

Dr. Pinter-Brown graduated from David Geffen School of Medicine at UCLA in 1980. Dr. Pinter-Brown is a member of ACP, ASCO and ASH.

Dr. Pinter-Brown is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.